Overview
The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6.
The patients will be evaluated at baseline and after three months of treatment with placebo or product.
Eligibility
Inclusion Criteria:
- uterine fibroid with diameter greater than or equal to 4cm or multiple fibroids
- eligible for surgery
- symptoms like menometrorrhagia or pelvic pain
Exclusion Criteria:
- BMI>30
- currently pregnant or breastfeeding
- diabetic
- suspect of malignancy
- diagnosis of cancer